Past Annual
Meeting Highlights

View DCT Insights and Spotlights from the DTRA 2024 Annual Meeting.

Group 8

The 2024 Annual Meeting

The 2024 DTRA Annual Meeting (November 12-16, 2024) brought together key leaders advancing the global adoption of decentralized methods. Discussions centered on crucial insights from regulatory and governmental bodies regarding the adoption of these methodologies, advancements in stabilizing decentralized research practices, and received valuable updates on the integration of DCTs within prominent biopharmaceutical companies and esteemed academic institutions.

DTRAWednesday_CR6_9272
Group 8

2024 Highlights

We kicked off the meeting with a Fireside Chat with Dr. Steffen Thirstrup, Chief Medical Officer of the European Medicines Agency, for a discussion around how the EMA is facilitating clinical trials in the EU and how the 27 member states are working together on coordinating these trials.

Group 8

Pharma Spotlights

Our Pharma Spotlight Presentations featured DTRA Members sharing their DCT Journeys, including:

Erica Lawson from Otsuka joined us to share about their first fully virtual trial and the lessons learned along the way.

Jeremy Price from Pfizer joined us to discuss the Pfizer Pledge of getting 60% remote trials across all therapeutic areas in 2022.

Hassan Kadhim from Bristol Myers Squibb shared their journey to climb the DCT mountain and what we can anticipate coming next.

Kim Hawkins from Sanofi discussed how they are disrupting the clinical trial process through DCTs.

DTRA_web-images_events_rectangle_001 (new)

Recorded Sessions

Registrants of the 2024 DTRA Annual Meeting can review recorded sessions in the Meeting App now.